RadNet will acquire Gleamer for up to $270 million, aiming to make DeepHealth the largest global provider of radiology clinical AI solutions.
Key Details
- 1RadNet acquires Paris-based AI firm Gleamer for up to $270 million.
- 2Gleamer serves over 700 customers across 44 countries, with FDA-cleared solutions for musculoskeletal, breast, lung, and brain imaging.
- 3The combined entity aims to become the largest provider of radiology clinical AI solutions globally.
- 4Gleamer's portfolio spans X-ray, mammography, CT, and MRI, and its products have analyzed over 30 million exams at more than 2,250 locations.
- 5Gleamer is expected to reach $30 million in annual recurring revenue in 2024, with compound annual growth over 90% from 2022–2025.
Why It Matters
This acquisition positions RadNet and its DeepHealth subsidiary as a leader in AI-driven radiology, further driving consolidation and innovation in imaging AI. The move underscores the growing demand for robust, FDA-cleared AI solutions across multiple imaging modalities.
Source
Radiology Business
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.